Nutrien (NYSE:NTR) had its price objective reduced by equities researchers at Morgan Stanley from $54.00 to $50.00 in a research report issued on Wednesday, BenzingaRatingsTable reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s target price would suggest a potential upside of 7.85% from the company’s previous close.

NTR has been the topic of a number of other reports. TD Securities cut their price objective on Nutrien from $69.00 to $67.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Scotiabank set a $60.00 target price on Nutrien and gave the company a “buy” rating in a research note on Thursday, September 26th. CIBC set a $70.00 target price on Nutrien and gave the company a “buy” rating in a report on Wednesday, October 9th. Berenberg Bank reaffirmed a “hold” rating and issued a $50.00 price target on shares of Nutrien in a research report on Wednesday, November 6th. Finally, Susquehanna Bancshares cut their price target on Nutrien from $65.00 to $61.00 in a report on Tuesday, November 19th. Five research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $60.13.

NYSE NTR opened at $46.36 on Wednesday. The company has a current ratio of 1.28, a quick ratio of 0.77 and a debt-to-equity ratio of 0.41. The company has a fifty day simple moving average of $48.03 and a 200 day simple moving average of $50.27. The company has a market cap of $26.66 billion, a P/E ratio of 17.23, a P/E/G ratio of 2.65 and a beta of 0.89. Nutrien has a 1 year low of $43.96 and a 1 year high of $56.00.

Nutrien (NYSE:NTR) last announced its earnings results on Monday, November 4th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.36 by ($0.12). The firm had revenue of $4.13 billion during the quarter, compared to the consensus estimate of $4.02 billion. Nutrien had a return on equity of 6.49% and a net margin of 20.95%. The business’s revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.47 EPS. Equities research analysts forecast that Nutrien will post 2.21 EPS for the current fiscal year.

Hedge funds have recently made changes to their positions in the business. Cutter & CO Brokerage Inc. bought a new position in Nutrien in the second quarter worth $2,749,000. Envestnet Asset Management Inc. boosted its holdings in Nutrien by 63.5% during the second quarter. Envestnet Asset Management Inc. now owns 320,058 shares of the company’s stock valued at $17,120,000 after purchasing an additional 124,251 shares in the last quarter. ETRADE Capital Management LLC boosted its holdings in Nutrien by 134.9% during the second quarter. ETRADE Capital Management LLC now owns 46,622 shares of the company’s stock valued at $2,492,000 after purchasing an additional 26,777 shares in the last quarter. Close Asset Management Ltd grew its stake in shares of Nutrien by 1.4% in the 3rd quarter. Close Asset Management Ltd now owns 55,980 shares of the company’s stock valued at $2,793,000 after purchasing an additional 783 shares during the period. Finally, Ferguson Wellman Capital Management Inc. grew its stake in shares of Nutrien by 3.2% in the 3rd quarter. Ferguson Wellman Capital Management Inc. now owns 164,089 shares of the company’s stock valued at $8,185,000 after purchasing an additional 5,102 shares during the period. Institutional investors own 63.95% of the company’s stock.

About Nutrien

Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.

Further Reading: Different Options Trading Strategies

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.